BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Pharm Country

  ZIOPHARM Oncology, Inc. to Present at the Biotechnology Industry Organization (BIO) Investor Forum

  October 3, 2007

   · 

  1 min read
• Business

  Nanobac Pharmaceuticals, Inc. Acquires Option to License Calgenex Corporation Technology to Treat Atherosclerosis and Prostatitis

  October 3, 2007

   · 

  1 min read
• Business

  Genaera Corporation Announces Licensing of Exclusive Rights of Pexiganan

  October 3, 2007

   · 

  6 min read
• Genetown

  Cubist Pharmaceuticals, Inc. Launches New Product Web Site

  October 3, 2007

   · 

  1 min read
• Bio NC

  Conversion Right Triggered for Laboratory Corporation of America Holdings’s Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021

  October 3, 2007

   · 

  1 min read
• Business

  Luminous Medical, Inc. Hire Jerry Workman as Director

  October 3, 2007

   · 

  1 min read
• Career Advice

  Career Pros: Before You Quit...

  October 3, 2007

   · 

  1 min read
• Business

  ICON Development Solutions Enhances Regulatory Team

  October 3, 2007

   · 

  1 min read
• Drug Development

  Newron Pharmaceuticals Starts Clinical Phase II Development of Ralfinamide in Post-Surgical Pain

  October 3, 2007

   · 

  3 min read
• Business

  Kissei Pharmaceutical Co., Ltd. and Eisai Company, Ltd. Sign License Agreement to Develop and Commercialize Glufast(R), a Rapid-acting Insulin Secretagogue in China

  October 3, 2007

   · 

  1 min read